Motegrity, Resolor (prucalopride) is a small molecule pharmaceutical. Prucalopride was first approved as Motegrity on 2009-10-14. It is used to treat constipation in the USA. It has been approved in Europe to treat constipation. It is known to target 5-hydroxytryptamine receptor 4.
|Drug Class||Sulpride derivatives|